CLINICAL_TRIALS
ClinicalTrials.gov record update
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells Injection (Anti CD30 CAR T Cells) in Patients With CD30+ Relapsed/Refractory Lymphoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05208853
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:19.978390+00:00
- Published At
- 2022-01-26T00:00:00+00:00
- Record Updated At
- 2022-01-26
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Hodgkin Lymphoma", "NK/T Cell Lymphoma", "Peripheral T Cell Lymphoma, Unspecified", "Angioimmunoblastic T-cell Lymphoma", "Anaplastic Large Cell Lymphoma", "Diffuse Large B Cell Lymphoma", "Mediastinal B-Cell Diffuse Large Cell Lymphoma", "Gray Zone Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-01-26"- protocolSection.identificationModule.nctId
"NCT05208853"- protocolSection.identificationModule.officialTitle
"An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells Injection (Anti CD30 CAR T Cells) in Patients With CD30+ Relapsed/Refractory Lymphoma"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.